Bovine Alphaherpesvirus 2 infections in Bavaria: an analysis of the current situation - several years after eradicating Bovine Alphaherpesvirus 1.
Bavaria
BoHV-1
BoHV-2
Bovine Alphaherpesvirus 1
Bovine Alphaherpesvirus 2
Bovine herpes mammillitis
Germany
Real time PCR
Seroprevalence
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
24 May 2020
24 May 2020
Historique:
received:
12
12
2019
accepted:
10
03
2020
entrez:
26
5
2020
pubmed:
26
5
2020
medline:
29
12
2020
Statut:
epublish
Résumé
Bavaria, a large federal state in Germany, has been declared free from infections with Bovine Alphaherpesvirus 1 (BoHV-1) in 2011. To maintain this status the cattle population is monitored for antibodies against BoHV-1 regularly. Several years ago, infrequent but recurrent problems in this sero-surveillance were statistically put into correlation with the presence of antibodies against Bovine Alphaherpesvirus 2 (BoHV-2). In Europe, BoHV-2 is primarily known as the agent causing bovine herpes mammillitis. However, very little information about BoHV-2 infections in Bavaria is available so far. Therefore, the aims of this study were to determine BoHV-2 seroprevalences and to detect virus genomes in potential clinical samples. 6801 blood sera of healthy cattle from all over Bavaria were tested for antibodies against BoHV-2, revealing an overall seroprevalence of 5.51%. Interestingly, seroprevalences markedly varied between the North and the South of Bavaria, namely from 0.42 to 11.17%. Concurrently, the previously reported relation between the epidemiologically inexplicable sero-reactivities in BoHV-1 ELISAs and the presence of BoHV-2 infections were statistically corroborated in this study. To detect BoHV-2 genomes a fast and sensitive real time PCR was established. Using a multiple PCR strategy, tissue samples from skin lesions at relevant localizations, corresponding lymph nodes, and trigeminal ganglia from 111 animals, as well as nasal swabs from 918 bovines with respiratory symptoms were tested. However, BoHV-2 genomes were not detected in any of these samples. BoHV-2 antibodies were found in samples from bovines all over Bavaria, albeit with an explicit South-North-divide. BoHV-2 genomes, however, could not be detected in any of the analyzed samples, indicating that acute clinical cases as well as obvious virus reactivation are relatively rare. Consequently, the future spread of BoHV-2 infections throughout Bavaria, particularly, after eradicating BoHV-1, has to be further monitored.
Sections du résumé
BACKGROUND
BACKGROUND
Bavaria, a large federal state in Germany, has been declared free from infections with Bovine Alphaherpesvirus 1 (BoHV-1) in 2011. To maintain this status the cattle population is monitored for antibodies against BoHV-1 regularly. Several years ago, infrequent but recurrent problems in this sero-surveillance were statistically put into correlation with the presence of antibodies against Bovine Alphaherpesvirus 2 (BoHV-2). In Europe, BoHV-2 is primarily known as the agent causing bovine herpes mammillitis. However, very little information about BoHV-2 infections in Bavaria is available so far. Therefore, the aims of this study were to determine BoHV-2 seroprevalences and to detect virus genomes in potential clinical samples.
RESULTS
RESULTS
6801 blood sera of healthy cattle from all over Bavaria were tested for antibodies against BoHV-2, revealing an overall seroprevalence of 5.51%. Interestingly, seroprevalences markedly varied between the North and the South of Bavaria, namely from 0.42 to 11.17%. Concurrently, the previously reported relation between the epidemiologically inexplicable sero-reactivities in BoHV-1 ELISAs and the presence of BoHV-2 infections were statistically corroborated in this study. To detect BoHV-2 genomes a fast and sensitive real time PCR was established. Using a multiple PCR strategy, tissue samples from skin lesions at relevant localizations, corresponding lymph nodes, and trigeminal ganglia from 111 animals, as well as nasal swabs from 918 bovines with respiratory symptoms were tested. However, BoHV-2 genomes were not detected in any of these samples.
CONCLUSIONS
CONCLUSIONS
BoHV-2 antibodies were found in samples from bovines all over Bavaria, albeit with an explicit South-North-divide. BoHV-2 genomes, however, could not be detected in any of the analyzed samples, indicating that acute clinical cases as well as obvious virus reactivation are relatively rare. Consequently, the future spread of BoHV-2 infections throughout Bavaria, particularly, after eradicating BoHV-1, has to be further monitored.
Identifiants
pubmed: 32448263
doi: 10.1186/s12917-020-02310-w
pii: 10.1186/s12917-020-02310-w
pmc: PMC7245791
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
149Subventions
Organisme : Bayerisches Staatsministerium für Umwelt und Verbraucherschutz
ID : 17-21
Références
Vet Rec. 1971 Apr 3;88(14):372
pubmed: 4324525
J Hyg (Lond). 1971 Jun;69(2):209-22
pubmed: 4326248
Infect Immun. 1984 Mar;43(3):1072-9
pubmed: 6199299
J Vet Diagn Invest. 2017 Sep;29(5):686-690
pubmed: 28423989
Intervirology. 1974;2(1):1-13
pubmed: 4362992
Arch Virol. 1979;60(1):51-8
pubmed: 226033
Arch Virol. 1982;72(1-2):75-81
pubmed: 6285866
Vet Rec. 1972 Oct 21;91(17):395-401
pubmed: 4343654
Vet Rec. 1972 Mar 18;90(12):325-35
pubmed: 4339363
Virus Genes. 1999;19(3):197-203
pubmed: 10595411
Schweiz Arch Tierheilkd. 1986 Jun;128(6):289-97
pubmed: 3018921
Vet Rec. 1978 May 27;102(21):464
pubmed: 208225
Schweiz Arch Tierheilkd. 1979 Nov;121(11):565-76
pubmed: 232571
J Virol Methods. 2017 Jan;239:38-41
pubmed: 27793645
J Am Vet Med Assoc. 1982 Apr 15;180(8):902-7
pubmed: 6282794
Vet Microbiol. 1984 Aug;9(4):329-44
pubmed: 6208673
Virus Genes. 1999;18(3):211-20
pubmed: 10456789
J Virol Methods. 2011 Jun;174(1-2):77-84
pubmed: 21458493
Res Vet Sci. 1975 Mar;18(2):208-15
pubmed: 165571
J Wildl Dis. 2005 Jul;41(3):482-8
pubmed: 16244057
J Wildl Dis. 1988 Apr;24(2):268-73
pubmed: 2836635
Res Vet Sci. 2009 Aug;87(1):161-6
pubmed: 19157471
Vet Rec. 2008 Jul 26;163(4):119-21
pubmed: 18660522
Br Vet J. 1969 Jul;125(7):317-25
pubmed: 4309314
Ann Radiol (Paris). 1982 Nov;25(7):455-9
pubmed: 6762133
Vet Rec. 1966 Apr 2;78(14):494-7
pubmed: 4289617
Res Vet Sci. 1973 Mar;14(2):139-44
pubmed: 4375832
Vet Microbiol. 2014 Jun 25;171(1-2):182-8
pubmed: 24725448
Virology. 1988 Aug;165(2):388-405
pubmed: 2841793
Am J Vet Res. 1969 Dec;30(12):2151-66
pubmed: 4311022
Am J Vet Res. 1980 Nov;41(11):1890-3
pubmed: 6259974
Schweiz Arch Tierheilkd. 2000 Jul;142(7):375-80
pubmed: 11008514
Tierarztl Prax. 1984;12(3):297-305
pubmed: 6093283
Vet Microbiol. 2012 Oct 12;159(3-4):282-90
pubmed: 22578637
Boll Ist Sieroter Milan. 1974;53(5):645-50
pubmed: 4377111